Evidence map›Paper›PMID 36727073›Full record

ArticleFrontiers in oncology2022

Mitochondrial plasticity supports proliferative outgrowth and invasion of ovarian cancer spheroids during adhesion.

Joseph P Grieco, Stephanie L E Compton, Nazia Bano, Lucy Brookover, Anna S Nichenko, Joshua C Drake, Eva M Schmelz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Joseph P GriecoGraduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, United States.
Stephanie L E ComptonDepartment of Human Nutrition, Foods and Exercise, Virginia Tech, Blacksburg, VA, United States.
Nazia BanoGraduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Blacksburg, VA, United States.
Lucy BrookoverDepartment of Human Nutrition, Foods and Exercise, Virginia Tech, Blacksburg, VA, United States.
Anna S NichenkoDepartment of Human Nutrition, Foods and Exercise, Virginia Tech, Blacksburg, VA, United States.
Joshua C DrakeDepartment of Human Nutrition, Foods and Exercise, Virginia Tech, Blacksburg, VA, United States.
Eva M SchmelzDepartment of Human Nutrition, Foods and Exercise, Virginia Tech, Blacksburg, VA, United States.
Virginia Tech · US

Funding

Translation initiation in cardiac intercellular communication and stress-induced remodelingR01HL132236 · NHLBI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI SMYTH, JAMES WILLIAM · 2017 to 2021
$2.0M
Targeting mitochondrial adaptations to suppress metastatic outgrowth in serous ovarian cancerF31CA261146 · NCI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI GRIECO, JOE · 2021 to 2021
$35k
NCI NIH HHS F31 CA261146NHLBI NIH HHS R01 HL132236
6 · The paper itself

Abstract

Background: Ovarian cancer cells aggregate during or after exfoliation from the primary tumor to form threedimensional spheroids. Spheroid formation provides a survival advantage during peritoneal dissemination in nutrient and oxygen-depleted conditions which is accompanied by a suppressed metabolic phenotype and fragmented mitochondria. Upon arrival to their metastatic sites, spheroids adhere to peritoneal organs and transition to a more epithelial phenotype to support outgrowth and invasion. In this study, we investigated the plasticity of mitochondrial morphology, dynamics, and function upon adhesion. Methods: Using our slow-developing (MOSE-L) and fast-developing (MOSE-LTICv) ovarian cancer models, we mimicked adhesion and reoxygenation conditions by plating the spheroids onto tissue culture dishes and changing culture conditions from hypoxia and low glucose to normoxia with high glucose levels after adhesion. We used Western Blot, microscopy and Seahorse analyses to determine the plasticity of mitochondrial morphology and functions upon adhesion, and the impact on proliferation and invasion capacities. Results: Independent of culture conditions, all spheroids adhered to and began to grow onto the culture plates. While the bulk of the spheroid was unresponsive, the mitochondrial morphology in the outgrowing cells was indistinguishable from cells growing in monolayers, indicating that mitochondrial fragmentation in spheroids was indeed reversible. This was accompanied by an increase in regulators of mitobiogenesis, PGC1a, mitochondrial mass, and respiration. Reoxygenation increased migration and invasion in both cell types but only the MOSE-L responded with increased proliferation to reoxygenation. The highly aggressive phenotype of the MOSE-LTICv was characterized by a relative independence of oxygen and the preservation of higher levels of proliferation, migration and invasion even in limiting culture conditions but a higher reliance on mitophagy. Further, the outgrowth in these aggressive cells relies mostly on proliferation while the MOSE-L cells both utilize proliferation and migration to achieve outgrowth. Suppression of proliferation with cycloheximide impeded aggregation, reduced outgrowth and invasion via repression of MMP2 expression and the flattening of the spheroids. Discussion: Our studies indicate that the fragmentation of the mitochondria is reversible upon adhesion. The identification of regulatory signaling molecules and pathways of these key phenotypic alterations that occur during primary adhesion and invasion is critical for the identification of druggable targets for therapeutic intervention to prevent aggressive metastatic disease.

Indexed as

adhesioncycloheximidemitobiogenesismitochondriamitophagyovarian cancer metabolismreoxygenationspheroid

Identifiers

PMID36727073
PMCPMC9884807
OpenAlexW4316363156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.